BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 15679448)

  • 1. Pathologic quiz case: a 61-year-old man with a papular rash in a capelike distribution. Agranular CD4+CD56+ hematodermic neoplasm (blastic natural killer cell lymphoma).
    Lum SJ; Jain K; Honda S
    Arch Pathol Lab Med; 2005 Feb; 129(2):e47-8. PubMed ID: 15679448
    [No Abstract]   [Full Text] [Related]  

  • 2. 'Agranular CD4+ CD56+ hematodermic neoplasm' (blastic NK-cell lymphoma) originates from a population of CD56+ precursor cells related to plasmacytoid monocytes.
    Petrella T; Comeau MR; Maynadié M; Couillault G; De Muret A; Maliszewski CR; Dalac S; Durlach A; Galibert L
    Am J Surg Pathol; 2002 Jul; 26(7):852-62. PubMed ID: 12131152
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TCL1 and CLA expression in agranular CD4/CD56 hematodermic neoplasms (blastic NK-cell lymphomas) and leukemia cutis.
    Petrella T; Meijer CJ; Dalac S; Willemze R; Maynadié M; Machet L; Casasnovas O; Vergier B; Teitell MA
    Am J Clin Pathol; 2004 Aug; 122(2):307-13. PubMed ID: 15323148
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Agranular CD4+ CD56+ CD123+ hematodermic neoplasm (blastic NK-cell lymphoma) revealed by cutaneous localization: 2 cases].
    Machet L; De Muret A; Wiezberka E; Bernez A; Abdallah-Lotf M; Linassier C; Petrella T
    Ann Dermatol Venereol; 2004 Nov; 131(11):969-73. PubMed ID: 15602384
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Agranular CD4+/CD56+ hematodermic neoplasm: a distinct entity described in the recent World Health Organization-European Organization for Research and Treatment of Cancer classification for cutaneous lymphomas.
    Niakosari F; Sur M
    Arch Pathol Lab Med; 2007 Jan; 131(1):149-51. PubMed ID: 17227117
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A CD56-negative case of blastic natural killer-cell lymphoma (agranular CD4+/CD56+ haematodermic neoplasm).
    Petrella T; Teitell MA; Spiekermann C; Meijer CJ; Franck F; Enache I
    Br J Dermatol; 2004 Jan; 150(1):174-6. PubMed ID: 14746651
    [No Abstract]   [Full Text] [Related]  

  • 7. Cutaneous CD4+/CD56+ hematodermic neoplasm.
    Zindanci I; Kavala M; Buyukbabani N; Kocaturk E; Koc M
    Indian J Dermatol Venereol Leprol; 2010; 76(6):723. PubMed ID: 21079332
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hematodermic CD4/CD56 neoplasm].
    Petrella T; Wechsler J; Courville P; de Muret A; Bosq J; Déchelotte P; Feuillard J; Durlach A; Vergier B
    Ann Pathol; 2004 Jun; 24(3):241-55; quiz 227. PubMed ID: 15480259
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD2-, CD4+, CD56+ agranular natural killer cell lymphoma of the skin.
    Uchiyama N; Ito K; Kawai K; Sakamoto F; Takaki M; Ito M
    Am J Dermatopathol; 1998 Oct; 20(5):513-7. PubMed ID: 9790118
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD4+/CD56+ Hematodermic neoplasm (plasmacytoid dendritic cell tumor).
    Shiman M; Marchione R; Ricotti C; Romanelli P; Alonso-Llamazares J
    Dermatol Online J; 2008 Nov; 14(11):5. PubMed ID: 19094843
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD4+/CD56+ hematodermic tumor: the features of an evolving entity and its relationship to dendritic cells.
    Herling M; Jones D
    Am J Clin Pathol; 2007 May; 127(5):687-700. PubMed ID: 17439829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD56-negative blastic natural killer-cell lymphoma (agranular CD4(+)/CD56(+) haematodermic neoplasm)?
    Kawai K
    Br J Dermatol; 2005 Feb; 152(2):369-70. PubMed ID: 15727657
    [No Abstract]   [Full Text] [Related]  

  • 13. Primary cutaneous CD4+/CD56+ hematodermic neoplasm (blastic NK-cell lymphoma): a report of five cases.
    Ng AP; Lade S; Rutherford T; McCormack C; Prince HM; Westerman DA
    Haematologica; 2006 Jan; 91(1):143-4. PubMed ID: 16434387
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Agranular CD4+/CD56+ cutaneous neoplasm.
    Touahri T; Belaouni H; Mossafa H; Pulik M; Bourguigna L; Ibbora C; Dal Soglio D; Davi F; Fourcade C
    Leuk Lymphoma; 2002 Jul; 43(7):1475-9. PubMed ID: 12389632
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of the plasmacytoid dendritic cell marker BDCA-2 supports a spectrum of maturation among CD4+ CD56+ hematodermic neoplasms.
    Jaye DL; Geigerman CM; Herling M; Eastburn K; Waller EK; Jones D
    Mod Pathol; 2006 Dec; 19(12):1555-62. PubMed ID: 16998465
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD4+/CD56+ hematodermic neoplasm: blastic NK cell lymphoma in a 6-year-old child: report of a case and review of literature.
    Eguaras AV; Lo RW; Veloso JD; Tan VG; Enriquez ML; Del Rosario ML
    J Pediatr Hematol Oncol; 2007 Nov; 29(11):766-9. PubMed ID: 17984695
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD4+ CD56+ haematodermic tumour (plasmacytoid dendritic cell neoplasm).
    Hamadani M; Magro CM; Porcu P
    Br J Haematol; 2008 Jan; 140(2):122. PubMed ID: 17991297
    [No Abstract]   [Full Text] [Related]  

  • 18. Blastic plasmacytoid dendritic cell neoplasm presenting as leukemia without cutaneous lesion.
    Awasthi NP; Qayoom S; Dabadghao S
    J Cancer Res Ther; 2017; 13(6):1056-1058. PubMed ID: 29237977
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Images for diagnosis. CD4+CD56+ hematodermic neoplasm in a child.
    Guo X; Li Q; Zhou CY
    Chin Med J (Engl); 2010 Feb; 123(3):379-81. PubMed ID: 20193266
    [No Abstract]   [Full Text] [Related]  

  • 20. Agranular CD4+CD56+ blastic natural killer leukemia/lymphoma.
    Kimura S; Kakazu N; Kuroda J; Akaogi T; Hayashi H; Nishida K; Abe T
    Ann Hematol; 2001 Apr; 80(4):228-31. PubMed ID: 11401089
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.